SCHEMBL681349

SCHEMBL681349

C=C(C(C)C)[C@H](CNCC1CC1)c1ccc(Br)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.39
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP1A2 P05177 2/20 0.34
BCHE P06276 3/20 0.33
AKT1 P31749 1/20 0.33
AKT2 P31751 1/20 0.33
AKT3 Q9Y243 1/20 0.33
EPHX1 P07099 1/20 0.33
EPHX2 P34913 1/20 0.33
HSD11B1 P28845 2/20 0.33
GPR88 Q9GZN0 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17803809 0.87 KEAP1 (0.37) NPC1RAB9AKMT2ABCHEAKT1
SCHEMBL680730 0.86 POLB (0.42) POLBHDAC3HDAC1HDAC2NPC1
SCHEMBL681299 0.86 AKT1 (0.43) POLBNPC1RAB9AKMT2AAKT1
SCHEMBL681567 0.86 AKT1 (0.43) POLBNPC1RAB9AKMT2AAKT1
SCHEMBL684410 0.83 CYP1A2 (0.42) POLBHDAC3HDAC1HDAC2NPC1
SCHEMBL681257 0.83 TEAD1 (0.42) AKT1AKT2AKT3EPHX2HSD11B1
SCHEMBL680195 0.82 AKT1 (0.36) POLBHDAC3HDAC1HDAC2RAB9A
SCHEMBL12194519 0.80 CYP3A4 (0.40) KMT2ACYP1A2CYP2D6
SCHEMBL2739192 0.80 HDAC3 (0.40) POLBHDAC3HDAC1HDAC2NPC1
SCHEMBL17803806 0.78 LMNA (0.37) POLBKMT2AAKT1AKT2AKT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359340-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-06-07 US disclosed
US-8063050-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2011-11-22 US disclosed